These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25849269)

  • 1. Harnessing gene repression to inhibit leukemia.
    Harte PJ; Ernst P
    Nat Med; 2015 Apr; 21(4):308-10. PubMed ID: 25849269
    [No Abstract]   [Full Text] [Related]  

  • 2. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
    Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
    Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for DOT1L in MLL-rearranged leukemias.
    Bernt KM; Armstrong SA
    Epigenomics; 2011 Dec; 3(6):667-70. PubMed ID: 22126283
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of DOT1L in the maintenance of leukemia gene expression.
    Wang X; Chen CW; Armstrong SA
    Curr Opin Genet Dev; 2016 Feb; 36():68-72. PubMed ID: 27151433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trithorax group genes in hematopoiesis.
    Chase J; Grembecka J; Maillard I
    Oncotarget; 2015 Jul; 6(20):17855-6. PubMed ID: 26257003
    [No Abstract]   [Full Text] [Related]  

  • 6. Epigenetics: Targeting leukemia on the DOT.
    Travers J; Blagg J; Workman P
    Nat Chem Biol; 2011 Aug; 7(10):663-5. PubMed ID: 21873997
    [No Abstract]   [Full Text] [Related]  

  • 7. NF-κB: a coordinator for epigenetic regulation by MLL.
    Goyama S; Mulloy JC
    Cancer Cell; 2013 Oct; 24(4):401-2. PubMed ID: 24135275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.
    Aikawa Y; Yamagata K; Katsumoto T; Shima Y; Shino M; Stanley ER; Cleary ML; Akashi K; Tenen DG; Kitabayashi I
    Cancer Sci; 2015 Mar; 106(3):227-36. PubMed ID: 25529853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L; Sun Y; Wang J; Jiang H; Muntean AG
    Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of MLL methyltransferase gene expression in larynx carcinoma.
    Figueiredo DL; do Amaral Rabello D; Zanette DL; Saggioro FP; Mamede RC; Zago MA; da Silva WA; Saldanha-Araújo F; Pittella Silva F
    Oncol Rep; 2015 Apr; 33(4):2017-22. PubMed ID: 25633166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery in rare indications: opportunities and challenges.
    Richon VM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():19-23. PubMed ID: 24319157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstructing the disease model and epigenetic networks for MLL-AF4 leukemia.
    Zeisig BB; Cheung N; Yeung J; So CW
    Cancer Cell; 2008 Nov; 14(5):345-7. PubMed ID: 18977321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 59 cases of congenital leukemia reported between 2001 and 2016.
    Zhang Q; Ren Z; Yang J; Yin A
    J Int Med Res; 2019 Oct; 47(10):4625-4635. PubMed ID: 31558073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL is essential for NUP98-HOXA9-induced leukemia.
    Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
    Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetic programs in MLL-rearranged leukemias.
    Bernt KM; Armstrong SA
    Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin control of gene expression: mixed-lineage leukemia methyltransferase SETs the stage for transcription.
    Slany RK
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14481-2. PubMed ID: 16203969
    [No Abstract]   [Full Text] [Related]  

  • 19. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
    Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
    Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages.
    Carson WF; Cavassani KA; Soares EM; Hirai S; Kittan NA; Schaller MA; Scola MM; Joshi A; Matsukawa A; Aronoff DM; Johnson CN; Dou Y; Gallagher KA; Kunkel SL
    J Immunol; 2017 Sep; 199(5):1865-1874. PubMed ID: 28733487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.